“Due to competitive concerns with Myogen's ambrisentan, which is expected to enter the market in 2007, timing is of the essence for Encysive.”
“Gilead has a medicine called ambrisentan for the same lung disease in the final stage of human testing generally required for regulatory approval.”
“Data on ambrisentan, however, has been very promising; many analysts think the drug can take on Actelion's similar Tracleer.”
“Myogen's lead drug, ambrisentan, is a treatment for a rare disease called pulmonary arterial hypertension, PAH, a blood pressure disorder of the lungs that makes it extremely difficult for patients to breathe.”
“GlaxoSmithKline, which markets Flolan, the current standard-of-care treatment, obtained non-U.S. marketing rights for Myogen's ambrisentan last March in exchange for U.S. rights for Flolan.”
“Myogen's lead drug candidate is ambrisentan, a new type of treatment for pulmonary arterial hypertension, a blood pressure disorder of the lungs.”
“Understanding the function of the lung could help in developing other drugs that might fit in with Cayston and ambrisentan.”
“Shares of Myogen fell 10% as investors were disappointed with a recently announced deal with British drug giant GlaxoSmithKline for experimental drug ambrisentan, a treatment for pulmonary arterial hypertension.”
“Separately, Myogen said it forged an alliance with British drug giant GlaxoSmithKline for experimental drug ambrisentan, a treatment for pulmonary arterial hypertension.”
“We are maintaining our 'hold' rating, as we expect near-term weakness driven by visibility on Myogen's ambrisentan and a potentially slow launch due to the wide acceptance of Pfizer's Revatio," the firm said.”
‘ambrisentan’ hasn't been added to any lists yet.
Looking for tweets for ambrisentan.